Table 1.
Tier | Definition |
---|---|
Tier 1 | WPV-endemic countries or countries that have reported a cVDPV2 since 2000 |
Tier 2 | Countries that have reported a cVDPV1/cVDPV3 since 2000 or large/medium-sizeda countries with DTP3 vaccine coverage of <80% in 2012, 2013, or 2014, according to WUENIC |
Tier 3 | Large/medium-sizeda countries adjacent to tier 1 countries that reported WPV since 2003 or countries that have experienced a WPV importation since 2011 |
Tier 4 | All other countries using OPV |
Abbreviations: cVDPV1, cVDPV2, and cVDPV3, circulating vaccine-derived poliovirus types 1, 2, and 3, respectively; DTP3, third dose of the diphtheria-tetanus-pertussis vaccine; IPV, inactivated poliovirus vaccine; OPV, oral poliovirus vaccine; WPV, wild poliovirus; WUENIC, World Health Organization/United Nations Children’s Fund Estimates of National Immunization Coverage.
aSmall, medium-sized, and large countries were defined as those with <20 000, 20000 to 1 million, or >1 million live births, respectively.